NGS of the patient’s tumor tissue, blood, and CSF identified mutations in tumor protein P53, retinoblastoma 1, and MYC proto-oncogene, BHLH transcription factor like across all 3 specimens. The gene discussed is TP53; the disease is neoplasm.